143 related articles for article (PubMed ID: 1246336)
21. Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.
Sissons JG; Liebowitch J; Amos N; Peters DK
J Clin Invest; 1977 Apr; 59(4):704-15. PubMed ID: 845257
[TBL] [Abstract][Full Text] [Related]
22. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
[TBL] [Abstract][Full Text] [Related]
23. The C3 nephritic factor (C3NeF) and the heat labile complement inactivator (HLCI) in chronic hypocomplementemic mesangioproliferative glomerulonephritis.
Berthoux FC; Carpenter CB; Traeger J; Merrill JP
Adv Nephrol Necker Hosp; 1974; 4():91-108. PubMed ID: 4220002
[No Abstract] [Full Text] [Related]
24. The alternative pathway of complement activation.
Götze O; Müller-Eberhard HJ
Adv Immunol; 1976; 24():1-35. PubMed ID: 798473
[No Abstract] [Full Text] [Related]
25. Complement activation in glomerulonephritis.
Baer D
N Engl J Med; 1977 Jun; 296(22):1299. PubMed ID: 859526
[No Abstract] [Full Text] [Related]
26. A case of hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor.
Seki M; Ohi H; Watanabe S; Kojima H; Fujita T; Hatano M
Nihon Jinzo Gakkai Shi; 1987 May; 29(5):585-8. PubMed ID: 3656714
[No Abstract] [Full Text] [Related]
27. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
Daha MR; Fearon DT; Austen KF
J Immunol; 1976 Jan; 116(1):1-7. PubMed ID: 1245733
[TBL] [Abstract][Full Text] [Related]
28. Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B.
Daha MR; Fearon DT; Austen KF
Immunology; 1976 Nov; 31(5):789-96. PubMed ID: 992711
[TBL] [Abstract][Full Text] [Related]
29. The glomerular complement receptor in immunologically mediated renal glomerular injury.
Gelfand MC; Shin ML; Nagle RB; Green I; Frank MM
N Engl J Med; 1976 Jul; 295(1):10-4. PubMed ID: 1272284
[TBL] [Abstract][Full Text] [Related]
30. Human glomerulonephritis and the C3 nephritic factor (C3NeF).
Berthoux FC; Carpenter CB; Freyria AM; Traeger J; Merrill JP
Clin Nephrol; 1976 Mar; 5(3):93-100. PubMed ID: 57022
[No Abstract] [Full Text] [Related]
31. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
Lévy M; Sich M; Habib R
Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
[TBL] [Abstract][Full Text] [Related]
32. [Glomerular localization of the early components of complement in glomerulonephritis].
Barbiano di Belgiojoso G; Tarantino A; Durante A; Guerra L
Minerva Nefrol; 1974; 21(3):169-78. PubMed ID: 4463297
[No Abstract] [Full Text] [Related]
33. [Complement system in glomerulonephritis. II. Detailed aspects].
Bodalski J; Narebska E; Jerzmanowski A
Pediatr Pol; 1980 Jun; 55(6):805-11. PubMed ID: 7413331
[No Abstract] [Full Text] [Related]
34. Glomerular deposition of Ss protein in murine immune complex glomerulonephritis.
Hoffstein PE; Hill C; Shreffler DC
Clin Immunol Immunopathol; 1976 Jul; 6(1):47-50. PubMed ID: 133012
[No Abstract] [Full Text] [Related]
35. The reactivity of the complement system.
Hadding U
Monogr Allergy; 1977; 12():36-45. PubMed ID: 335218
[No Abstract] [Full Text] [Related]
36. Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF).
Daha MR; Fearon DT; Austen KF
J Immunol; 1976 Feb; 116(2):568-70. PubMed ID: 1249423
[No Abstract] [Full Text] [Related]
37. [Significance of the study of complement in glomerulonephritis. Research on some serum complement fractions and their detection in renal biopsies with the use of microscopy and immunofluorescence].
Martini PF; Camussi G; Segoloni G; Rotunno M; Triolo G; Mangiarotti G; Messina M; Caramello E
Recenti Prog Med; 1978 Mar; 64(3):354-73. PubMed ID: 351753
[No Abstract] [Full Text] [Related]
38. Analysis of glomerular complement receptors in various types of glomerulonephritis.
Sobel AT; Gabay YE; Lagrue G
Clin Immunol Immunopathol; 1976 Jul; 6(1):94-101. PubMed ID: 949882
[No Abstract] [Full Text] [Related]
39. The authors reply:
Servais A; Noel LH; Lesavre P; Frémeaux-Bacchi V
Kidney Int; 2013 Feb; 83(2):332-3. PubMed ID: 23364592
[No Abstract] [Full Text] [Related]
40. The natural modulation of the amplification phase of complement activation.
Fearon DT; Daha MR; Weiler JM; Austen KF
Transplant Rev; 1976; 32():12-25. PubMed ID: 62426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
